Swing trade. Expecting reversal from the support level . Goals: 1. $1.75 2. $2 Put stop based on your risk tolerance Follow me @Trader in the PersonaFi App.
Up on positive news. Could attempt a breakout here. Downward resiatnce 1.77. Main resiatnce 1.97 Target 2.80
Ampio Pharmaceuticals exists for over 10 years now. The science behind its leading drug is solid. There were many trials - in none any safety concern rose. Most promising indication is OAK and arthritis in general. Phase-3 results are due to late September. In the last confernece management had clearly stated this timeline. Other than that, the drug showed...
- Forming bullish flag on 2h - Forming symmetrical triangle on 1d - Upcoming earnings Target Price #1: 2.35 Target Price #2: 2.85
coming off of a double top and consolidated nicely also has a beta around 3 so reversal should start when biotech stops falling as a whole\ not investment advice just ideas
I like the proximity to the POC line and the close above the 20ema. I looks like the 9ema should start crossing the 20ema any day now. Also the RSI is very low and the MACD is rising. I think this offers a low risk entry point for a swing trade entry. I will place a stop at $1.36
Holding horizontal support Daily and 4hr hidden bullish divergence on the MACD and RSI Stop = Below horizontal support Target = Resistance @ $2.11
AMPIO has been in the news for treatment of COVID, and most recently for 2 trials treating 2 different types of inflammatory diseases, one is kidney related and would be very important in future treatments of Kidney Disease with chronic inflammation. I believe this would be the best case scenario, if found to be effective. Current price, $1.20 - Technically I...
Stimulus seems to be leaving the spotlight. Waiting to see if it starts to shift back to Covid testing and treatment. Once I see Covid penny stocks pumping, I will jump in on this and wait for the inevitable pump! AMPE received a approval from the FDA Clinical Trial Protocol of Inhaled Ampion on Sep 21st. Also was featured on a local Fox News Channel.
Stimulus seems to be leaving the spotlight. Waiting to see if it starts to shift back to Covid testing and treatment. Once I see Covid penny stocks pumping, I will jump in on this and wait for the inevitable pump! AMPE received a approval from the FDA Clinical Trial Protocol of Inhaled Ampion on Sep 21st. Also was featured on a local Fox News Channel.
Looking for AMPE to continue it's march towards my target of $4 in the weeks ahead.
Just a chart I put up for a fellow trader who is knew to trading and wanted to know what I look at for swings. Found this stock using a scanner with personal settings.
Stop loss and take profit levels can be changed personally if you wa1t to trade more safely! AMPE is in a current uptrend, and I think it will continue to go upwards before a possible breakdown. Expecting it to reach "Take profit level" within 5-10days. MACD showing buy signal as well
We are really liking the chart on $AMPE. You have the rounding bottom and there looks to be accumulation going on. Currently trading at $.62 a share, the 52-week low is $.35 a share. We believe $AMPE has breakout written all over it and there is an upcoming catalyst that can send the stock flying higher. The company is due to hear from the FDA shortly. Here's...